Neurovascular Stent
- UID
- IMP/MD/2021/000389_3913dc6b8c05895a3dace9b711e83551_1ad2221e2f24568acc170d86b0b099e3
- Device class
- Class D
- Brand name
- CREDO Stent
- License holder
- N-VASCULAR TECHNOLOGY PRIVATE LIMITED
- Approving authority
- CDSCO
- Product information
- Used in combination with the NeuroSpeed PTA Balloon Catheter, the CREDO Stent is indicated to increase the vessel diameter of intracranial arteries (CREDO Stent) that are suitable for and accessible to the system (CREDO Stent) in patients: • with arteriosclerotic (CREDO Stent) vessel constrictions (CREDO Stent) with significant circulatory disturbance (CREDO Stent), • with recurrent symptoms in spite of antiaggregation therapy (CREDO Stent) after at least two events (CREDO Stent). • over 18 years old • whose last stroke occurred at least 7 days before and in whom the impairment after stroke has a rating of 3 or less on the modified Rankin scale (CREDO Stent) at the time of treatment or • with acute vascular occlusion due to high-grade intracranial stenosis in which alternative therapy concepts are not considered or fail
Neurovascular Stent is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/MD/2021/000389_3913dc6b8c05895a3dace9b711e83551_1ad2221e2f24568acc170d86b0b099e3. This device is marketed under the brand name CREDO Stent. The license holder is N-VASCULAR TECHNOLOGY PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.